COO logo

Cooper Companies (COO)

Profile

Full Name

The Cooper Companies, Inc.

Ticker Symbol

COO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 21, 1983

Indexes

S&P 500

Website

http://www.coopercos.com

Employees

16000

Key Details

Price

$72.19(+1.45%)

Market cap

Last Dividend

$0.01

TTM Dividend yield

-

Annual revenue

$3.90B(+8.41% YoY)

Annual EPS

$1.96(+32.43% YoY)

PE ratio

35.04

Next earnings date

Aug 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $72.19
    COO price is $72.19

    30-Day Relative Volume

    1.10
    COO 30-day relative volume is 1.10

    Price Performance

    Price Today change

    +1.45%
    COO price is up +1.45% today

    Price YTD change

    -21.47%
    COO price is down -21.47% since January 1st

    Price 1-year change

    -16.44%
    COO price is down -16.44% year-on-year

    Price 3-year change

    -9.34%
    COO price is down -9.34% over the past 3 years

    Price Range

    Price All-time high

    $115.90
    COO price is currently -37.71% below its historical high of $115.90

    Price 3-year low

    $61.05
    COO price is currently +18.24% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $14.40B
    COO market capitalization is $14.40 billion

    Market cap 3-year change

    -8.35%
    COO market capitalization is down -8.35% over the past 3 years

    Market cap All-time high

    $22.48B
    COO market capitalization is currently -35.93% below its historical high of $22.48 billion

    Market cap sector rank

    94.27%
    COO market capitalization is higher than 94.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.2%
    COO shares outstanding is up +0.2% year-on-year

    Shares Outstanding 3-Year Change

    +1.1%
    COO shares outstanding is up +1.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.68
    COO beta is 0.68

    200-day SMA

    $90.91
    COO price is currently -20.59% below its 200-day simple moving average

    50-day SMA

    $76.44
    COO price is currently -5.57% below its 50-day simple moving average

    RSI

    45.42
    COO 14-day relative strength index is 45.42

    Volume

    1.10
    COO 30-day relative volume is 1.10

    ATR

    $1.90
    COO average true range is $1.90

    10-day Historical Volatility

    21.46%
    COO 10-day historical volatility is 21.46%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.01
    COO last dividend was $0.01 per share, with an ex-dividend date of July 26, 2023

    Next Dividend

    -
    COO next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    COO annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    COO annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    COO annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    COO annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    COO annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    COO annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    COO annual payout ratio is 0.00%

    Dividends paid

    $0.00
    COO annual dividends paid is $0.00

    Free cash flow

    $288.10M
    COO annual free cash flow is $288.10 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.90B
    COO annual revenue is $3.90 billion

    Revenue Analysts estimate

    $4.12B
    COO annual revenue is currently -5.42% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8.41%
    COO annual revenue is up +8.41% year-on-year

    Revenue Sector rank

    90.27%
    COO annual revenue is higher than 90.27% of companies in Healthcare sector

    EPS

    EPS

    $1.96
    COO annual earnings per share is $1.96

    EPS Analysts estimate

    $4.06
    COO annual earnings per share is currently -51.74% lower than the consensus analysts' forecast

    EPS 1-year change

    +32.43%
    COO annual earnings per share is up +32.43% year-on-year

    EPS Sector rank

    92.09%
    COO annual earnings per share is higher than 92.09% of companies in Healthcare sector

    Profit

    Gross profit

    $2.60B
    COO annual gross profit is $2.60 billion

    Gross margin

    66.64%
    COO annual gross profit margin is 66.64%

    Operating profit

    $705.70M
    COO annual operating income is $705.70 million

    Operating margin

    18.12%
    COO annual operating profit margin is 18.12%

    Net income

    $392.30M
    COO annual net profit is $392.30 million

    Net margin

    10.07%
    COO annual net profit margin is 10.07%

    Expenses

    Total expenses

    $3.19B
    COO annual total expenses is $3.19 billion

    Operating expenses

    $1.89B
    COO annual total operating expenses is $1.89 billion

    Cost of goods sold

    $1.30B
    COO annual cost of goods sold is $1.30 billion

    Selling, general & administrative expenses

    $1.53B
    COO annual SGA is $1.53 billion

    Depreciation and amortization

    $375.10M
    COO annual depreciation & amortization is $375.10 million

    Interest expense

    $114.30M
    COO annual interest expense is $114.30 million

    Income tax

    $190.00M
    COO annual income tax is $190.00 million

    EBIT & EBITDA

    EBIT

    $696.60M
    COO annual earnings before interest & taxes is $696.60 million

    EBITDA

    $897.80M
    COO annual EBITDA is $897.80 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $12.32B
    COO annual total assets is $12.32 billion

    Non current assets

    $10.36B
    COO annual long term assets is $10.36 billion

    Current assets

    $1.95B
    COO annual total current assets is $1.95 billion

    Cash and cash equivalents

    $107.60M
    COO annual cash & cash equivalents is $107.60 million

    Accounts receivable

    $717.00M
    COO annual accounts receivable is $717.00 million

    Inventory

    $802.70M
    COO annual inventory is $802.70 million

    Liabilities

    Total liabilities

    $4.23B
    COO annual total liabilities is $4.23 billion

    Long term liabilities

    $3.21B
    COO annual total long term liabilities is $3.21 billion

    Current liabilities

    $1.02B
    COO annual total current liabilities is $1.02 billion

    Accounts payable

    $260.50M
    COO annual accounts payable is $260.50 million

    Debt

    Total debt

    $2.58B
    COO annual total debt is $2.58 billion

    Total debt 1-year change

    +0.56%
    COO annual total debt is up +0.56% year-on-year

    Long term debt

    $2.55B
    COO annual long term debt is $2.55 billion

    Short term debt

    $33.30M
    COO annual short term debt is $33.30 million

    Equity & Capital

    Shareholders equity

    $8.08B
    COO annual stockholders equity is $8.08 billion

    Book value

    $8.08B
    COO annual book value is $8.08 billion

    Retained earnings

    $7.27B
    COO annual retained earnings is $7.27 billion

    Working capital

    $928.70M
    COO annual working capital is $928.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $709.30M
    COO annual cash flow from operations is $709.30 million

    Cash from operations 1-year change

    +16.76%
    COO annual cash flow from operations is up +16.76% year-on-year

    Cash from investing

    -$764.60M
    COO annual cash flow from investing activities is -$764.60 million

    Cash from investing 1-year change

    -70.29%
    COO annual cash flow from investing activities is down -70.29% year-on-year

    Cash from financing

    $39.20M
    COO annual cash flow from financing activities is $39.20 million

    Cash from financing 1-year change

    +122.54%
    COO annual cash flow from financing activities is up +122.54% year-on-year

    CAPEX

    CAPEX

    $421.20M
    COO annual capital expenditures is $421.20 million

    CAPEX 1-year change

    +7.31%
    COO annual capital expenditures is up +7.31% year-on-year

    Free Cash Flow

    Free cash flow

    $288.10M
    COO annual free cash flow is $288.10 million

    Free cash flow 1-year change

    +34%
    COO annual free cash flow is up +34% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    66.64%
    COO annual gross profit margin is 66.64%

    Operating margin

    18.12%
    COO annual operating profit margin is 18.12%

    Net margin

    10.07%
    COO annual net profit margin is 10.07%

    ROA & ROE

    ROA

    3.27%
    COO annual return on assets is 3.27%

    ROE

    5.02%
    COO annual return on equity is 5.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    35.04
    COO price to earnings ratio is 35.04

    PE ratio Sector rank

    65.89%
    COO price to earnings ratio is higher than 65.89% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.74
    COO price to book ratio is 1.74

    PB ratio Sector rank

    54.46%
    COO price to book ratio is higher than 54.46% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.61
    COO price to sales ratio is 3.61

    PS ratio Sector rank

    56.29%
    COO price to sales ratio is higher than 56.29% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $16.87B
    COO enterprise value is $16.87 billion

    Enterprise value Sector rank

    94.31%
    COO enterprise value is higher than 94.31% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    15.35
    COO EV/EBITDA is 15.35

    EV/EBITDA Sector rank

    89.03%
    COO EV/EBITDA is higher than 89.03% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.91
    COO annual current ratio is 1.91

    Quick ratio

    1.12
    COO annual quick ratio is 1.12

    Leverage

    Debt to equity

    0.32
    COO annual debt to equity ratio is 0.32

    Interest coverage ratio

    6.09
    COO annual interest coverage ratio is 6.09

    Risk & Stability

    Piotroski F-Score

    8
    COO piotroski f-score is 8

    Altman Z-Score

    3.46
    COO altman z-score is 3.46

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Needham
    Buy
    May 30, 25 Wells Fargo
    Overweight
    May 30, 25 Piper Sandler
    Overweight
    May 30, 25 JP Morgan
    Neutral
    May 30, 25 Baird
    Outperform
    May 22, 25 Needham
    Hold
    Mar 7, 25 Stifel
    Buy
    Mar 7, 25 Piper Sandler
    Overweight
    Mar 7, 25 Needham
    Hold
    Mar 7, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with COO included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Cooper Companies?
    • Does Cooper Companies pay dividends?
    • What sector is Cooper Companies in?
    • What industry is Cooper Companies in?
    • What country is Cooper Companies based in?
    • When did Cooper Companies go public?
    • Is Cooper Companies in the S&P 500?
    • Is Cooper Companies in the NASDAQ 100?
    • Is Cooper Companies in the Dow Jones?
    • When was Cooper Companies's last earnings report?
    • When does Cooper Companies report earnings?
    • Should I buy Cooper Companies stock now?

    What is the ticker symbol for Cooper Companies?

    The ticker symbol for Cooper Companies is NASDAQ:COO

    Does Cooper Companies pay dividends?

    No, Cooper Companies does not pay dividends

    What sector is Cooper Companies in?

    Cooper Companies is in the Healthcare sector

    What industry is Cooper Companies in?

    Cooper Companies is in the Medical Instruments & Supplies industry

    What country is Cooper Companies based in?

    Cooper Companies is headquartered in United States

    When did Cooper Companies go public?

    Cooper Companies's initial public offering (IPO) was on January 21, 1983

    Is Cooper Companies in the S&P 500?

    Yes, Cooper Companies is included in the S&P 500 index

    Is Cooper Companies in the NASDAQ 100?

    No, Cooper Companies is not included in the NASDAQ 100 index

    Is Cooper Companies in the Dow Jones?

    No, Cooper Companies is not included in the Dow Jones index

    When was Cooper Companies's last earnings report?

    Cooper Companies's most recent earnings report was on May 29, 2025

    When does Cooper Companies report earnings?

    The next expected earnings date for Cooper Companies is Aug 28, 2025

    Should I buy Cooper Companies stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page